Mr. Speaker, I have just a few remarks to address in this debate. They take the form of certain questions which I would be grateful if the Minister of Health would take the opportunity to address before this debate comes to an end.
Bill C-51 amends the Food and Drugs Act to modernize the regulatory system for foods and therapeutic products, such as contact lenses, breast implants, pharmaceuticals, and so forth. The bill seeks to improve the surveillance of benefits and risks of therapeutic products through their life cycle. It is intended to improve the compliance and enforcement measures by corporations to encourage them to report adverse reactions or potential health threats associated with market products. To this end, the bill proposes to give very substantial regulatory powers to the minister. That is the type, broadly, of legislation we are dealing with in Bill C-51.
We in the Liberal Party obviously are committed, as we always have been, to improving the health and safety of Canadians and to making sure that we have an appropriate legislative framework to that end. We obviously support measures which strengthen the regulatory process to ensure that Canadians are able to have access to the safest and most effective food and therapeutic products.
However, members will have noticed as this debate has gone on that a number of problems have been brought to the attention of the House which need to be addressed. I would like to highlight a couple of those and ask the government for its considered response.
I am sure that all members of Parliament have received letters from a variety of people across the country with respect to the professional services of naturopathic doctors. The statement has been made by those who defend this legislation that the bill actually has nothing to do with that broad category of activity.
I would like to read briefly into the record one of these letters that I have received from a constituent in Regina. I would ask the minister or the parliamentary secretary to be kind enough to provide responses to the questions that this individual has raised. I will read portions of the letter as follows:
I am writing to you as one of your constituents to express my concerns about Bill C-51 and the impact it will have on the ability of my naturopathic doctor (ND) to treat my health concerns safely and effectively....
As an informed patient I have chosen to be treated by a naturopathic doctor utilizing natural therapies and substances to ensure optimal health. I would like some assurances that my choice to see a naturopathic doctor...will not be negatively impacted by Bill C-51.
I have the following questions:
1. Will Bill C-51 exclude my ND [naturopathic doctor] from having access to all the products that he/she needs to treat all my health concerns?
2. Will Bill C-51 result in fewer natural health products being available in the Canadian marketplace?
3. Will inspectors have the ability to enter premises under the search and seizure provisions without a warrant or a judge's approval?
That is the end of the bulk of the letter. I am sure the tone of that letter is familiar to many members in the House who would have received similar letters. It is important for the government to put on the record the official response to those concerns so that Canadians who have those kinds of concerns can be reassured about the impact of this legislation.
Finally, I have a suggestion to offer to the Minister of Health. It has been said in parliamentary circles in the last several days that when this bill gets to the committee stage, the government intends to bring forward what are considered to be significant amendments. We do not know if that is in fact the case, but the rumour that seems to be circulating in the Standing Committee on Health is that when Bill C-51 arrives in the committee officially, there will be significant amendments to the bill brought forward by the government itself.
That presents a problem for the House. We are now coming near the end, I suspect, of the debate at second reading and very shortly we will be called upon to vote on approval in principle of this legislation before it goes to the Standing Committee on Health for detailed consideration clause by clause. I would suggest that before the House is asked to vote at second reading on approval in principle of the bill, the House needs to know what amendments the minister has in mind. Are there amendments that are likely to be forthcoming at the committee stage? Are they significant amendments as they have been portrayed? If they are significant amendments, they may well affect the principle of the bill.
Second reading, as we all know, is approval in principle. Once we vote on approval in principle at second reading, a lot of water has gone under the bridge. It is important for the House to know exactly on what it is voting.
How can the House approve in principle Bill C-51 now if we are not told specifically what that principle is? Will that principle change? Are these amendments that the minister proposes to introduce in the committee so fundamental that they might take this bill in a new or different direction that is not contemplated by the scheme of the bill that is presently before the House?
There are two alternatives. First, before this debate comes to an end, it would be very helpful if the Minister of Health or the parliamentary secretary or someone on behalf of the government would simply inform the House now of the type of amendments the government may have in mind when the bill gets to the committee stage. They have been portrayed generally as significant, but we have not yet been told the detail.
If we are to vote on approval in principle of this bill which at a later stage is going to be amended, we are being asked now to buy a pig in a poke. I would simply ask the parliamentary secretary or the minister to tell us what the amendments are so we can make a considered judgment about Bill C-51 when we are asked to vote on it in principle at second reading.
The other alternative is if the government is not in a position to publish its amendments now or to inform the House about what those amendments might be eventually, the government could choose to simply suspend the debate at second reading. Instead of forcing the House now to vote in principle on something that may change at a subsequent date, the government could change its tactic and adopt the procedure that is set out in Standing Order 73(1), which is to send Bill C-51 to the Standing Committee on Health before the vote at second reading.
If that course of action were adopted, it would then be possible for members of Parliament to consider all dimensions of what is contained in Bill C-51, both the substance of the bill as it now exists and any proposed amendments the government might have in mind, without first having to vote on a principle, the substance of which we are not sure because it might change when it gets to the committee.
Either give us the amendments now so that we can know what the government has in mind or send the bill to committee before second reading so that members of Parliament will have more scope to change the bill if the principles contained in the amendments the government has in mind are not consistent with what the House would prefer.
Those are the points, briefly, that I wish to make on Bill C-51. They are offered in a spirit of trying to be constructive in this debate and bringing forward the concerns that people in my constituency, at least some of them, have expressed. I would ask the government if not now then at some other time in the debate to make an effort to respond to those points in the constructive spirit in which they are offered.